The mTOR pathway in the antiphospholipid syndrome

Abstract

This perspective discussed the available evidence on the involvement of mTOR pathway in antiphospholipid syndrome (APS), from the aspects of endothelial cells, platelets, monocytes and anti-phospholipid antibodies (PLs), which may lead to future therapeutic applications of mTOR inhibition in APS.

Keywords

• antiphospholipid syndrome
• mtor
• autoimmune disease